Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2021-10-17 2021-10-13
Drug Identification Number 02014874 02014874
Brand name 70% DEXTROSE INJECTION USP 70% DEXTROSE INJECTION USP
Common or Proper name 70% Dextrose Injection, USP 70% Dextrose Injection, USP
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients DEXTROSE DEXTROSE
Strength(s) 70G 70G
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 3000mL Bag 3000mL Bag
ATC code B05BA B05BA
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-10-16 2021-10-16
Actual start date 2021-10-16 2021-10-16
Estimated end date 2021-11-05 2021-11-05
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments Baxter is experiencing a supply disruption on 70% Dextrose 3L format (Baxter code JB0297) which will continue until the first week of November. Limited supply of the 2L format (Baxter code 2B0296H) is available. Please contact your Baxter Nutrition Sales Specialist if you have any questions or require additional information. Baxter is experiencing a supply disruption on 70% Dextrose 3L format (Baxter code JB0297) which will continue until the first week of November. Limited supply of the 2L format (Baxter code 2B0296H) is available. Please contact your Baxter Nutrition Sales Specialist if you have any questions or require additional information.
Health Canada comments